The stock of Structure Therapeutics Inc. (NASDAQ:GPCR) decreased by -$1.78 on Friday to finish at $27.57, down -6.06 percent. The last five days have seen an average of 1,037,200 shares of common stock traded. The average number of shares traded over the last 20 days was 529,650, while the average volume over the last 50 days totaled 361,546.
GPCR stock dropped -12.42% since last month. On 08/07/23, the company’s shares reached a one-month low of $25.86. The stock touched a high of $42.55, after rallying from a low of $20.80 in 52 weeks. The price of GPCR stock has risen by 6.04%. Still, the stock price is down -35.21% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Financial Health
For the three months ended June 29, Structure Therapeutics Inc.’s quick ratio was 22.40, while its current ratio was 22.40, indicating its ability to pay off its debt. Based on annual data, it had gross profit of $1.26 million and revenue of $52.56 million.
Earnings Surprise
According to Structure Therapeutics Inc.’s quarterly financial report for the quarter that ended June 29, it had $184.0 million in cash and short-term investments. A higher net income was reported in the quarter under review than the previous quarter. It was predicted that Structure Therapeutics Inc.’s quarterly earnings would be -$0.6, but it ended up being -$0.28, beating the consensus by -114.30%. EBITDA was -$27.56 million for the quarter. At the end of Structure Therapeutics Inc.’s most recent quarter ended June 29, its liabilities totaled 15.01 million, while its total debt was $73000.0. Equity owned by shareholders amounts to $114.81 million.
Technical Picture
Here’s a quick look at Structure Therapeutics Inc.’s (GPCR) price momentum from a technical perspective. As of 11 August, the RSI 9-day stood at 35.91%, suggesting the stock is Neutral, with a 116.09% historical volatility rate.
The stochastic %K and %D were 21.03% and 22.91% respectively, while the average true range (ATR) was 3.11. Based on the 14-day stochastic reading of 14.48%, the RSI (14) reading is 38.74%. On the 9-day MACD Oscillator, the stock is at -1.74, and the 14-day reading is at -3.73.
Analyst Ratings
In its analyst report released on July 27, 2023, Piper Sandler began covering Structure Therapeutics Inc. (NASDAQ: GPCR). The stock was rated as an Overweight by the brokerage firm. Analysts have assigned Structure Therapeutics Inc. (GPCR) an Buy rating. GPCR is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 5 others recommend it as a buy.
What is GPCR’s price target for the next 12 months?
The current consensus forecast for the stock is between $40.00 and $58.00, with a median target price of $50.00. In analyzing these forecasts, the average price target given by analysts for Structure Therapeutics Inc. (GPCR) is $48.80.
